Opendata, web and dolomites

UbiCODE SIGNED

European Research Training to Decipher The Ub Code : identification of potential biomarkers and drug targets

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 UbiCODE project word cloud

Explore the words cloud of the UbiCODE project. It provides you a very rough idea of what is the project "UbiCODE" about.

regulate    modification    molecules    expanded    homeostatic    manner    ub    right    cell    modified    cellular    time    neurodegeneration    acetylation    translational    infections    complexity    latest    pathologies    scientists    inflammation    ways    modifications    members    discovery    homeostasis    ubl    unknown    biochemical    technological    intricate    language    effort    ubicode    status    ubiquitin    unprecedented    fundamental    pharmacological    regulation    explore    defects    area    landscape    pharmaceutical    phosphorylation    universal    heterologous    unsuspected    joint    forming    multiple    model    sumo    protein    essential    raquo    organisms    levels    collaborative    efforts    modify    industry    stability    proteins    compartment    post    efficient    themselves    enzymes    deciphered    decrypt    laquo    code    family    equilibrium    function    interconnected    therapeutic    molecular    attractive    ptms    clinical    nedd8    hold    chains    cancer    chemical    intervention    interaction    localisation    understand    interestingly    ptm    multidisciplinary   

Project "UbiCODE" data sheet

The following table provides information about the project.

Coordinator
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS 

Organization address
address: RUE MICHEL ANGE 3
city: PARIS
postcode: 75794
website: www.cnrs.fr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 3˙407˙194 €
 EC max contribution 3˙407˙194 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2017
 Funding Scheme MSCA-ITN-ETN
 Starting year 2018
 Duration (year-month-day) from 2018-01-01   to  2021-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS FR (PARIS) coordinator 525˙751.00
2    UNIVERSITY OF DUNDEE UK (DUNDEE) participant 546˙575.00
3    ACADEMISCH ZIEKENHUIS LEIDEN NL (LEIDEN) participant 510˙748.00
4    NOVO NORDISK A/S DK (BAGSVAERD) participant 290˙081.00
5    THE UNIVERSITY OF LIVERPOOL UK (LIVERPOOL) participant 273˙287.00
6    FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH FONDATION CH (BASEL) participant 265˙226.00
7    INSTITUT FUR MOLEKULARE BIOLOGIE GGMBH DE (MAINZ) participant 249˙216.00
8    JOHANN WOLFGANG GOETHE-UNIVERSITATFRANKFURT AM MAIN DE (FRANKFURT AM MAIN) participant 249˙216.00
9    MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV DE (MUENCHEN) participant 249˙216.00
10    ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS ES (DERIO VIZCAYA) participant 247˙872.00
11    MEDICAL RESEARCH COUNCIL UK (SWINDON) participant 0.00
12    Basque Country University ES (Leioa) partner 0.00
13    Hybrigenics FR (PARIS) partner 0.00
14    Merck KGaA DE (DARMSTADT) partner 0.00
15    Nova Medical School PT (Lisboa) partner 0.00
16    Novartis CH (Basel) partner 0.00
17    The Naked Scientists Ltd UK (Cambridge) partner 0.00
18    UbiQ NL (AMSTERDAM) partner 0.00
19    Ubiquigent Ltd UK (Dundee) partner 0.00
20    YELLOW RESEARCH NL (AMSTERDAM) partner 0.00

Map

 Project objective

Essential role of protein modification by members of the Ubiquitin family: Post-translational modifications (PTM) by members of the Ubiquitin (Ub) family represent an efficient way to regulate protein function at several levels: to change their localisation, activity, their interaction with partner proteins or their stability at the right time and cellular compartment, according to the cell requirements. Defects in this homeostatic equilibrium result in pathologies such as cancer, neurodegeneration, inflammation or multiple infections. For this reason, this research area has become very attractive for fundamental scientists as well as for the pharmaceutical industry aiming to identify potential targets for therapeutic intervention. Ub family members hold a homeostatic equilibrium within the cell and are interconnected in various ways including the regulation of enzymes that control the modified status of target proteins. Interestingly, Ub and Ub-like (UbL) proteins can modify themselves, forming intricate and complex chains. This landscape has recently expanded with the discovery of the formation of heterologous chains among UbL molecules including SUMO or NEDD8 but also other PTMs such as phosphorylation or acetylation. This unsuspected complexity of what is now known as the «Ubiquitin Code», which is an unknown universal language that needs to be deciphered to understand protein homeostasis and its associated pathologies. To decrypt this complex code requires joint collaborative multidisciplinary efforts at all levels, including the use of distinct molecular systems and model organisms and the latest technological developments to explore chemical, biochemical, molecular, pharmacological and clinical aspects of protein modification by members of the Ub family. UbiCODE represents an unprecedented effort to understand this code in an integrated manner.

 Deliverables

List of deliverables.
Supervisory Board Other 2020-04-16 14:16:31
Outreach and research article publications, meetings, events Documents, reports 2020-04-16 14:16:26
UbiCODE website launched and updated and presence in social media Websites, patent fillings, videos etc. 2020-04-16 14:16:21

Take a look to the deliverables list in detail:  detailed list of UbiCODE deliverables.

 Publications

year authors and title journal last update
List of publications.
2020 Zuzanna Kozicka, Georg Petzold, Nicolas H. Thomä
Taking the Brakes Off Targeted Protein Degradation
published pages: 16-18, ISSN: 2451-9456, DOI: 10.1016/j.chembiol.2019.12.010
Cell Chemical Biology 27/1 2020-02-05
2020 David A. Pérez Berrocal, Katharina F. Witting, Huib Ovaa, Monique P. C. Mulder
Hybrid Chains: A Collaboration of Ubiquitin and Ubiquitin-Like Modifiers Introducing Cross-Functionality to the Ubiquitin Code
published pages: , ISSN: 2296-2646, DOI: 10.3389/fchem.2019.00931
Frontiers in Chemistry 7 2020-02-04

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "UBICODE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "UBICODE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

ARCH (2019)

AGE-RELATED CHANGES IN HEMATOPOIESIS

Read More  

CHANGE (2019)

Cultural Heritage Analysis for New GEnerations

Read More  

SAMCAPS (2018)

Self-Assembled MicroCAPSules: Synthesis, Characterization, and Eco-friendly Application in Home Care Products

Read More